← back to search

Niloufer Khan

City Of Hope National Medical Center · US
Area of research
Pathology and Forensic Medicine · Dermatology
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Cutaneous lymphoproliferative disorders research, T-cell and Retrovirus Studies, and Viral-associated cancers and disorders.
h-index
15
citations
2,786
works
79
NIH funding
primary concept
Medicine
email

Recent publications

AHOD2131: A Randomized Phase 3 Response-Adapted Trial Comparing Standard Therapy with Immuno-Oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma
Blood 2023cited by 15position: middledoi
Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma
Journal of Clinical Oncology 2021cited by 56position: middledoi
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation
New England Journal of Medicine 2020cited by 729position: middledoi
Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study
Blood 2020cited by 80position: firstdoi
ADDITION OF LENALIDOMIDE TO R‐CHOP (R2CHOP) IMPROVES OUTCOMES IN NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): FIRST REPORT OF ECOG‐ACRIN1412 A RANDOMIZED PHASE 2 US INTERGROUP STUDY OF R2CHOP VS R‐CHOP
Hematological Oncology 2019cited by 35position: middledoi
Multicenter Microbiota Analysis Indicates That Pre-HCT Microbiota Injury Is Prevalent across Geography and Predicts Poor Overall Survival
Biology of Blood and Marrow Transplantation 2019cited by 0position: middledoi
Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis
BMJ 2018cited by 572position: middledoi
Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia
Leukemia & lymphoma/Leukemia and lymphoma 2017cited by 39position: firstdoi
<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
New England Journal of Medicine 2016cited by 783position: middledoi
Psychological morbidities in adolescent and young adult blood cancer patients during curative‐intent therapy and early survivorship
Cancer 2016cited by 76position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Wendy Stock · Leukemia Research Foundation2 papers (2016–2017)Ann S. LaCasce · Harvard University1 papers (2023–2023)Ann E. Slingerland · Memorial Sloan Kettering Cancer Center1 papers (2019–2019)John Slingerland · City Of Hope National Medical Center1 papers (2019–2019)Kara M. Kelly · Women & Children's Hospital of Buffalo1 papers (2023–2023)Lisa Roth · University of Iowa1 papers (2023–2023)Sarah A. Milgrom · University of Colorado Denver1 papers (2023–2023)Hongtao Liu · University of Wisconsin–Madison1 papers (2017–2017) · 1 papers (2018–2018)Steve Cho · Neurological Surgery1 papers (2023–2023) · 1 papers (2019–2019)Ziwei Wang · Nanjing University of Chinese Medicine1 papers (2018–2018) · 1 papers (2019–2019)Susan K. Parsons · Tufts University1 papers (2023–2023)Molly Maloy · Memorial Sloan Kettering Cancer Center1 papers (2019–2019)Shrujal S. Baxi · Cambridge Health Alliance1 papers (2018–2018)Lori Muffly · Stanford Health Care1 papers (2016–2016)Marcel R.M. van den Brink · Beckman Research Institute1 papers (2019–2019)Thomas E. Witzig · Toyota Motor Corporation (Switzerland)1 papers (2019–2019)Yue Wu · University of Florida1 papers (2023–2023)